{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T14:04:11Z","timestamp":1789567451018,"version":"build-2803163510"},"reference-count":138,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T00:00:00Z","timestamp":1787270400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T00:00:00Z","timestamp":1787270400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"CINTESIS, R&D Unit","award":["UIDB\/4255\/2020"],"award-info":[{"award-number":["UIDB\/4255\/2020"]}]},{"name":"RISE, Associated Laboratory","award":["LA\/P\/0053\/2020"],"award-info":[{"award-number":["LA\/P\/0053\/2020"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs Aging"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s40266-026-01329-2","type":"journal-article","created":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T14:17:12Z","timestamp":1787321832000},"page":"817-836","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Opioids to Treat Chronic Pain in the Older Adult: A Clinical Consensus to Guarantee Safety and Avoid Adverse Events"],"prefix":"10.1007","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6623-7420","authenticated-orcid":false,"given":"Hugo","family":"Ribeiro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o Rocha","family":"Neves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulo","family":"Roberto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catarina Cunha","family":"Sousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diogo","family":"Barros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joana Brand\u00e3o","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreia","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Dourado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o Paulo","family":"Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In\u00eas","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo","family":"Napole\u00e3o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana Frag\u00e3o","family":"Marques","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00edlia","family":"Dourado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Paulo","family":"Andrade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,21]]},"reference":[{"issue":"6","key":"1329_CR1","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1097\/j.pain.0000000000000160","volume":"156","author":"RD Treede","year":"2015","unstructured":"Treede RD, Rief W, Barke A, Aziz Q, Bennett MI, Benoliel R, et al. A classification of chronic pain for ICD-11. Pain. 2015;156(6):1003\u20137. https:\/\/doi.org\/10.1097\/j.pain.0000000000000160.","journal-title":"Pain"},{"issue":"10","key":"1329_CR2","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1016\/j.jpain.2022.05.001","volume":"23","author":"JC Ballantyne","year":"2022","unstructured":"Ballantyne JC, Sullivan MD. Is chronic pain a disease? J Pain. 2022;23(10):1651\u201365. https:\/\/doi.org\/10.1016\/j.jpain.2022.05.001.","journal-title":"J Pain"},{"issue":"10289","key":"1329_CR3","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.1016\/S0140-6736(21)00393-7","volume":"397","author":"SP Cohen","year":"2021","unstructured":"Cohen SP, Vase L, Hooten WM. Chronic pain: an update on burden, best practices, and new advances. Lancet. 2021;397(10289):2082\u201397. https:\/\/doi.org\/10.1016\/S0140-6736(21)00393-7.","journal-title":"Lancet"},{"issue":"3","key":"1329_CR4","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.anclin.2019.04.012","volume":"37","author":"J Schwan","year":"2019","unstructured":"Schwan J, Sclafani J, Tawfik VL. Chronic pain management in the elderly. Anesthesiol Clin. 2019;37(3):547\u201360. https:\/\/doi.org\/10.1016\/j.anclin.2019.04.012.","journal-title":"Anesthesiol Clin"},{"issue":"12","key":"1329_CR5","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1016\/j.jpain.2021.05.007","volume":"22","author":"R Li","year":"2021","unstructured":"Li R, Dworkin RH, Chapman BP, Becerra AZ, Yang L, Mooney CJ, et al. Moderate to severe chronic pain in later life: risk and resilience factors for recovery. J Pain. 2021;22(12):1657\u201371. https:\/\/doi.org\/10.1016\/j.jpain.2021.05.007.","journal-title":"J Pain"},{"issue":"2","key":"1329_CR6","doi-asserted-by":"publisher","first-page":"e273","DOI":"10.1016\/j.bja.2019.03.023","volume":"123","author":"SEE Mills","year":"2019","unstructured":"Mills SEE, Nicolson KP, Smith BH. Chronic pain: a review of its epidemiology and associated factors in population-based studies. Br J Anaesth. 2019;123(2):e273\u201383. https:\/\/doi.org\/10.1016\/j.bja.2019.03.023.","journal-title":"Br J Anaesth"},{"key":"1329_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fpain.2021.721357","author":"SE Nadeau","year":"2021","unstructured":"Nadeau SE, Wu JK, Lawhern RA. Opioids and chronic pain: an analytic review of the clinical evidence. Front Pain Res. 2021. https:\/\/doi.org\/10.3389\/fpain.2021.721357.","journal-title":"Front Pain Res"},{"issue":"1","key":"1329_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/applbiosci4010003","volume":"4","author":"S Duarte","year":"2025","unstructured":"Duarte S, Rocha-Neves J, Dourado M, Ribeiro H. Does the use of two major opioids have an impact on improving pain treatment and quality of life in cancer patients? A literature review. Appl Biosci. 2025;4(1):3. https:\/\/doi.org\/10.3390\/applbiosci4010003.","journal-title":"Appl Biosci"},{"key":"1329_CR9","unstructured":"Sampognaro G, Harrell R. Multimodal postoperative pain control after orthopaedic surgery]. StatPearls [Internet] Treasure Island (FL): StatPearls Publishing; 2026. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK572072\/. Accessed 29 Jan 2023."},{"issue":"37","key":"1329_CR10","doi-asserted-by":"publisher","first-page":"6079","DOI":"10.2174\/138161212803582423","volume":"18","author":"T Heiskanen","year":"2012","unstructured":"Heiskanen T, Kalso E. Non-analgesic effects of opioids: interactions between opioids and other drugs. Curr Pharm Des. 2012;18(37):6079\u201389. https:\/\/doi.org\/10.2174\/138161212803582423.","journal-title":"Curr Pharm Des"},{"issue":"2","key":"1329_CR11","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1111\/bph.12695","volume":"172","author":"A Chabot\u2010Dor\u00e9","year":"2015","unstructured":"Chabot\u2010Dor\u00e9 A, Schuster DJ, Stone LS, Wilcox GL. Analgesic synergy between opioid and \u03b1 2 \u2010adrenoceptors. Br J Pharmacol. 2015;172(2):388\u2013402. https:\/\/doi.org\/10.1111\/bph.12695.","journal-title":"Br J Pharmacol"},{"issue":"4","key":"1329_CR12","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.anclin.2007.07.006","volume":"25","author":"H Knotkova","year":"2007","unstructured":"Knotkova H, Pappagallo M. Adjuvant analgesics. Anesthesiol Clin. 2007;25(4):775\u201386. https:\/\/doi.org\/10.1016\/j.anclin.2007.07.006.","journal-title":"Anesthesiol Clin"},{"issue":"3","key":"1329_CR13","doi-asserted-by":"publisher","first-page":"233","DOI":"10.32385\/rpmgf.v37i3.12852","volume":"37","author":"H Ribeiro","year":"2021","unstructured":"Ribeiro H, Rocha-Neves J, Lopes-Mota C, Teixeira-Ver\u00edssimo M, Dourado M, Andrade J. Opioides em ambulat\u00f3rio na dor n\u00e3o oncol\u00f3gica: uma revis\u00e3o sobre os desafios da farmacologia no envelhecimento. Rev Port Clin Geral. 2021;37(3):233\u201341. https:\/\/doi.org\/10.32385\/rpmgf.v37i3.12852.","journal-title":"Rev Port Clin Geral"},{"issue":"3","key":"1329_CR14","doi-asserted-by":"publisher","DOI":"10.12998\/wjcc.v5.i3.73","volume":"5","author":"F Guerriero","year":"2017","unstructured":"Guerriero F. Guidance on opioids prescribing for the management of persistent non-cancer pain in older adults. World J Clin Cases. 2017;5(3):73. https:\/\/doi.org\/10.12998\/wjcc.v5.i3.73.","journal-title":"World J Clin Cases"},{"issue":"4","key":"1329_CR15","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.jpainsymman.2019.10.022","volume":"59","author":"S Pask","year":"2020","unstructured":"Pask S, Dell\u2019Olio M, Murtagh FEM, Boland JW. The effects of opioids on cognition in older adults with cancer and chronic noncancer pain: a systematic review. J Pain Symptom Manag. 2020;59(4):871-893.e1. https:\/\/doi.org\/10.1016\/j.jpainsymman.2019.10.022.","journal-title":"J Pain Symptom Manag"},{"issue":"4","key":"1329_CR16","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1111\/j.1533-2500.2008.00204.x","volume":"8","author":"J Pergolizzi","year":"2008","unstructured":"Pergolizzi J, B\u00f6ger RH, Budd K, Dahan A, Erdine S, Hans G, et al. Opioids and the management of chronic severe pain in the elderly: consensus statement of an international expert panel with focus on the six clinically most often used World Health Organization step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone). Pain Pract. 2008;8(4):287\u2013313. https:\/\/doi.org\/10.1111\/j.1533-2500.2008.00204.x.","journal-title":"Pain Pract"},{"issue":"11","key":"1329_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25115925","volume":"25","author":"LM Rosendo","year":"2024","unstructured":"Rosendo LM, Rosado T, Zandonai T, Rincon K, Peir\u00f3 AM, Barroso M, et al. Opioid monitoring in clinical settings: strategies and implications of tailored approaches for therapy. Int J Mol Sci. 2024;25(11):5925. https:\/\/doi.org\/10.3390\/ijms25115925.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1329_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40122-017-0068-3","volume":"6","author":"JV Pergolizzi","year":"2017","unstructured":"Pergolizzi JV, LeQuang JA, Berger GK, Raffa RB. The basic pharmacology of opioids informs the opioid discourse about misuse and abuse: a review. Pain Ther. 2017;6(1):1\u201316. https:\/\/doi.org\/10.1007\/s40122-017-0068-3.","journal-title":"Pain Ther"},{"issue":"2","key":"1329_CR19","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1177\/204946370800100202","volume":"1","author":"J Williams","year":"2008","unstructured":"Williams J. Basic opioid pharmacology. Rev Pain. 2008;1(2):2\u20135. https:\/\/doi.org\/10.1177\/204946370800100202.","journal-title":"Rev Pain"},{"issue":"1","key":"1329_CR20","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1177\/2049463712438493","volume":"6","author":"H Pathan","year":"2012","unstructured":"Pathan H, Williams J. Basic opioid pharmacology: an update. Br J Pain. 2012;6(1):11\u20136. https:\/\/doi.org\/10.1177\/2049463712438493.","journal-title":"Br J Pain"},{"issue":"3","key":"1329_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr7103a1","volume":"71","author":"D Dowell","year":"2022","unstructured":"Dowell D, Ragan KR, Jones CM, Baldwin GT, Chou R. CDC clinical practice guideline for prescribing opioids for pain\u2014United States, 2022. MMWR Recomm Rep. 2022;71(3):1\u201395. https:\/\/doi.org\/10.15585\/mmwr.rr7103a1.","journal-title":"MMWR Recomm Rep"},{"key":"1329_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.bjao.2023.100141","volume":"6","author":"DG Lambert","year":"2023","unstructured":"Lambert DG. Opioids and opioid receptors; understanding pharmacological mechanisms as a key to therapeutic advances and mitigation of the misuse crisis. BJA Open. 2023;6:100141. https:\/\/doi.org\/10.1016\/j.bjao.2023.100141.","journal-title":"BJA Open"},{"issue":"4","key":"1329_CR23","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1111\/j.1476-5381.2011.01335.x","volume":"164","author":"MM Morgan","year":"2011","unstructured":"Morgan MM, Christie MJ. Analysis of opioid efficacy, tolerance, addiction and dependence from cell culture to human. Br J Pharmacol. 2011;164(4):1322\u201334. https:\/\/doi.org\/10.1111\/j.1476-5381.2011.01335.x.","journal-title":"Br J Pharmacol"},{"issue":"6","key":"1329_CR24","doi-asserted-by":"publisher","first-page":"e168","DOI":"10.1016\/j.bja.2018.12.023","volume":"122","author":"MH Algera","year":"2019","unstructured":"Algera MH, Kamp J, van der Schrier R, van Velzen M, Niesters M, Aarts L, et al. Opioid-induced respiratory depression in humans: a review of pharmacokinetic\u2013pharmacodynamic modelling of reversal. Br J Anaesth. 2019;122(6):e168\u201379. https:\/\/doi.org\/10.1016\/j.bja.2018.12.023.","journal-title":"Br J Anaesth"},{"issue":"7","key":"1329_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2023.107121","volume":"26","author":"NJ Malcolm","year":"2023","unstructured":"Malcolm NJ, Palkovic B, Sprague DJ, Calkins MM, Lanham JK, Halberstadt AL, et al. Mu-opioid receptor selective superagonists produce prolonged respiratory depression. iScience. 2023;26(7):107121. https:\/\/doi.org\/10.1016\/j.isci.2023.107121.","journal-title":"iScience"},{"issue":"2","key":"1329_CR26","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1124\/jpet.119.258566","volume":"371","author":"R Torralva","year":"2019","unstructured":"Torralva R, Janowsky A. Noradrenergic mechanisms in fentanyl-mediated rapid death explain failure of naloxone in the opioid crisis. J Pharmacol Exp Ther. 2019;371(2):453\u201375. https:\/\/doi.org\/10.1124\/jpet.119.258566.","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"1329_CR27","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.bja.2023.10.041","volume":"132","author":"DSK Samways","year":"2024","unstructured":"Samways DSK. Clarifying intrinsic efficacy, partial agonism, and full agonism: the case of buprenorphine. Br J Anaesth. 2024;132(2):431\u20132. https:\/\/doi.org\/10.1016\/j.bja.2023.10.041.","journal-title":"Br J Anaesth"},{"issue":"1","key":"1329_CR28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0256752","volume":"17","author":"LM Moss","year":"2022","unstructured":"Moss LM, Algera MH, Dobbins R, Gray F, Strafford S, Heath A, et al. Effect of sustained high buprenorphine plasma concentrations on fentanyl-induced respiratory depression: a placebo-controlled crossover study in healthy volunteers and opioid-tolerant patients. PLoS\u00a0One. 2022;17(1):e0256752. https:\/\/doi.org\/10.1371\/journal.pone.0256752.","journal-title":"PLoS\u00a0One"},{"issue":"18","key":"1329_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/molecules25184163","volume":"25","author":"W Sadee","year":"2020","unstructured":"Sadee W, Oberdick J, Wang Z. Biased opioid antagonists as modulators of opioid dependence: opportunities to improve pain therapy and opioid use management. Molecules. 2020;25(18):4163. https:\/\/doi.org\/10.3390\/molecules25184163.","journal-title":"Molecules"},{"issue":"7","key":"1329_CR30","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1080\/14656566.2020.1732349","volume":"21","author":"LE Hood","year":"2020","unstructured":"Hood LE, Leyrer-Jackson JM, Olive MF. Pharmacotherapeutic management of co-morbid alcohol and opioid use. Expert Opin Pharmacother. 2020;21(7):823\u201339. https:\/\/doi.org\/10.1080\/14656566.2020.1732349.","journal-title":"Expert Opin Pharmacother"},{"issue":"3","key":"1329_CR31","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1093\/bja\/aev540","volume":"116","author":"M Al-Hashimi","year":"2016","unstructured":"Al-Hashimi M, McDonald J, Thompson JP, Lambert DG. Evidence for nociceptin\/orphanin FQ (NOP) but not \u00b5 (MOP), \u03b4 (DOP) or \u03ba (KOP) opioid receptor mRNA in whole human blood. Br J Anaesth. 2016;116(3):423\u20139. https:\/\/doi.org\/10.1093\/bja\/aev540.","journal-title":"Br J Anaesth"},{"issue":"2","key":"1329_CR32","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1111\/bph.12810","volume":"172","author":"AMW Taylor","year":"2015","unstructured":"Taylor AMW, Roberts KW, Pradhan AA, Akbari HA, Walwyn W, Lutfy K, et al. Anti\u2010nociception mediated by a \u03ba opioid receptor agonist is blocked by a \u03b4 receptor agonist. Br J Pharmacol. 2015;172(2):691\u2013703. https:\/\/doi.org\/10.1111\/bph.12810.","journal-title":"Br J Pharmacol"},{"issue":"6","key":"1329_CR33","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/S0301-0082(02)00009-6","volume":"66","author":"MJ Millan","year":"2002","unstructured":"Millan MJ. Descending control of pain. Prog Neurobiol. 2002;66(6):355\u2013474. https:\/\/doi.org\/10.1016\/S0301-0082(02)00009-6.","journal-title":"Prog Neurobiol"},{"key":"1329_CR34","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.conb.2014.07.010","volume":"29","author":"BK Lau","year":"2014","unstructured":"Lau BK, Vaughan CW. Descending modulation of pain: the GABA disinhibition hypothesis of analgesia. Curr Opin Neurobiol. 2014;29:159\u201364. https:\/\/doi.org\/10.1016\/j.conb.2014.07.010.","journal-title":"Curr Opin Neurobiol"},{"key":"1329_CR35","doi-asserted-by":"publisher","DOI":"10.1111\/ejn.70275","author":"WWJ van Strien","year":"2025","unstructured":"van Strien WWJ, Hollmann MW. Pain perception and modulation: fundamental neurobiology and recent advances. Eur J Neurosci. 2025. https:\/\/doi.org\/10.1111\/ejn.70275.","journal-title":"Eur J Neurosci."},{"key":"1329_CR36","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3389\/fnins.2018.00886","volume":"27","author":"LM Lueptow","year":"2018","unstructured":"Lueptow LM, Fakira AK, Bobeck EN. The contribution of the descending pain modulatory pathway in opioid tolerance. Front Neurosci. 2018;27:12. https:\/\/doi.org\/10.3389\/fnins.2018.00886.","journal-title":"Front Neurosci"},{"issue":"10","key":"1329_CR37","doi-asserted-by":"publisher","first-page":"2320","DOI":"10.1111\/bph.14982","volume":"177","author":"BK Lau","year":"2020","unstructured":"Lau BK, Winters BL, Vaughan CW. Opioid presynaptic disinhibition of the midbrain periaqueductal grey descending analgesic pathway. Br J Pharmacol. 2020;177(10):2320\u201332. https:\/\/doi.org\/10.1111\/bph.14982.","journal-title":"Br J Pharmacol"},{"issue":"21","key":"1329_CR38","doi-asserted-by":"publisher","DOI":"10.3390\/ijms262110692","volume":"26","author":"R Salda\u00f1a","year":"2025","unstructured":"Salda\u00f1a R, Carrascosa AJ, Torregrosa AB, Navarrete F, Garc\u00eda-Guti\u00e9rrez MS, Manzanares J. Dual role of the spinal endocannabinoid system in response to noxious stimuli: antinociceptive pathways and neuropathic pain mechanisms. Int J Mol Sci. 2025;26(21):10692. https:\/\/doi.org\/10.3390\/ijms262110692.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1329_CR39","doi-asserted-by":"publisher","first-page":"414","DOI":"10.3390\/ijms22010414","volume":"22","author":"A Comitato","year":"2021","unstructured":"Comitato A, Bardoni R. Presynaptic inhibition of pain and touch in the spinal cord: from receptors to circuits. Int J Mol Sci. 2021;22(1):414. https:\/\/doi.org\/10.3390\/ijms22010414.","journal-title":"Int J Mol Sci"},{"issue":"42","key":"1329_CR40","doi-asserted-by":"publisher","first-page":"7333","DOI":"10.2174\/138161281942140105160625","volume":"19","author":"J Lamberts","year":"2014","unstructured":"Lamberts J, Traynor J. Opioid receptor interacting proteins and the control of opioid signaling. Curr Pharm Des. 2014;19(42):7333\u201347. https:\/\/doi.org\/10.2174\/138161281942140105160625.","journal-title":"Curr Pharm Des"},{"issue":"1","key":"1329_CR41","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/s41392-024-01803-6","volume":"9","author":"M Zhang","year":"2024","unstructured":"Zhang M, Chen T, Lu X, Lan X, Chen Z, Lu S. G protein-coupled receptors (GPCRs): advances in structures, mechanisms and drug discovery. Signal Transduct Target Ther. 2024;9(1):88. https:\/\/doi.org\/10.1038\/s41392-024-01803-6.","journal-title":"Signal Transduct Target Ther"},{"issue":"6","key":"1329_CR42","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1097\/ALN.0b013e318238bba6","volume":"115","author":"R Al-Hasani","year":"2011","unstructured":"Al-Hasani R, Bruchas MR. Molecular mechanisms of opioid receptor-dependent signaling and behavior. Anesthesiology. 2011;115(6):1363\u201381. https:\/\/doi.org\/10.1097\/ALN.0b013e318238bba6.","journal-title":"Anesthesiology"},{"issue":"1","key":"1329_CR43","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1177\/2050640618818305","volume":"7","author":"AD Farmer","year":"2019","unstructured":"Farmer AD, Drewes AM, Chiarioni G, De Giorgio R, O\u2019Brien T, Morlion B, et al. Pathophysiology and management of opioid-induced constipation: European expert consensus statement. United Eur Gastroenterol J. 2019;7(1):7\u201320. https:\/\/doi.org\/10.1177\/2050640618818305.","journal-title":"United Eur Gastroenterol J."},{"key":"1329_CR44","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3389\/fnins.2023.1134842","volume":"6","author":"N Lynch","year":"2023","unstructured":"Lynch N, Lima JD, Spinieli RL, Kaur S. Opioids, sleep, analgesia and respiratory depression: their convergence on Mu (\u03bc)-opioid receptors in the parabrachial area. Front Neurosci. 2023;6:17. https:\/\/doi.org\/10.3389\/fnins.2023.1134842.","journal-title":"Front Neurosci"},{"issue":"1206","key":"1329_CR45","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1093\/postmj\/qgaf211","volume":"102","author":"E Becker","year":"2026","unstructured":"Becker E, Madi MY, Magee M, Ansari N, Ruffle JK, Syn WK, et al. Opioid induced constipation: mechanisms and management. Postgrad Med J. 2026;102(1206):367\u201377. https:\/\/doi.org\/10.1093\/postmj\/qgaf211.","journal-title":"Postgrad Med J"},{"key":"1329_CR46","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.neuropharm.2017.12.032","volume":"131","author":"MZ Imam","year":"2018","unstructured":"Imam MZ, Kuo A, Ghassabian S, Smith MT. Progress in understanding mechanisms of opioid-induced gastrointestinal adverse effects and respiratory depression. Neuropharmacology. 2018;131:238\u201355. https:\/\/doi.org\/10.1016\/j.neuropharm.2017.12.032.","journal-title":"Neuropharmacology"},{"issue":"1","key":"1329_CR47","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.bbi.2009.08.004","volume":"24","author":"MR Hutchinson","year":"2010","unstructured":"Hutchinson MR, Zhang Y, Shridhar M, Evans JH, Buchanan MM, Zhao TX, et al. Evidence that opioids may have toll-like receptor 4 and MD-2 effects. Brain Behav Immun. 2010;24(1):83\u201395. https:\/\/doi.org\/10.1016\/j.bbi.2009.08.004.","journal-title":"Brain Behav Immun"},{"key":"1329_CR48","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01455","author":"P Zhang","year":"2020","unstructured":"Zhang P, Yang M, Chen C, Liu L, Wei X, Zeng S. Toll-like receptor 4 (TLR4)\/opioid receptor pathway crosstalk and impact on opioid analgesia, immune function, and gastrointestinal motility. Front Immunol. 2020. https:\/\/doi.org\/10.3389\/fimmu.2020.01455.","journal-title":"Front Immunol"},{"key":"1329_CR49","doi-asserted-by":"publisher","DOI":"10.1089\/pmr.2023.0049","author":"JJ Bettinger","year":"2024","unstructured":"Bettinger JJ, Friedman BC. Opioids and immunosuppression: clinical evidence, mechanisms of action, and potential therapies. Palliat Med Rep. 2024. https:\/\/doi.org\/10.1089\/pmr.2023.0049.","journal-title":"Palliat Med Rep"},{"issue":"6","key":"1329_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e16407","volume":"9","author":"J Cheng","year":"2023","unstructured":"Cheng J, He Z, Chen Q, Lin J, Peng Y, Zhang J, et al. Histone modifications in cocaine, methamphetamine and opioids. Heliyon. 2023;9(6):e16407. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e16407.","journal-title":"Heliyon"},{"issue":"12","key":"1329_CR51","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.2217\/fon.11.124","volume":"7","author":"BN Singh","year":"2011","unstructured":"Singh BN, Zhou H, Li J, Tipton T, Wang B, Shao G, et al. Preclinical studies on histone deacetylase inhibitors as therapeutic reagents for endometrial and ovarian cancers. Future Oncol. 2011;7(12):1415\u201328. https:\/\/doi.org\/10.2217\/fon.11.124.","journal-title":"Future Oncol"},{"key":"1329_CR52","unstructured":"Dean L, Kane M. Codeine Therapy and CYP2D6 Genotype 2012 Sep 20. Pratt VM, Scott SA, Pirmohamed M, et al. Editors medical genetics summaries [Internet] Bethesda (MD): National Center for Biotechnology Information (US); 2012. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK100662\/. Accessed 26 Mar 2026."},{"key":"1329_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.112060","volume":"142","author":"L Magarbeh","year":"2021","unstructured":"Magarbeh L, Gorbovskaya I, Le Foll B, Jhirad R, M\u00fcller DJ. Reviewing pharmacogenetics to advance precision medicine for opioids. Biomed Pharmacother. 2021;142:112060. https:\/\/doi.org\/10.1016\/j.biopha.2021.112060.","journal-title":"Biomed Pharmacother"},{"issue":"2","key":"1329_CR54","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/clpt.2011.287","volume":"91","author":"KR Crews","year":"2012","unstructured":"Crews KR, Gaedigk A, Dunnenberger HM, Klein TE, Shen DD, Callaghan JT, et al. Clinical pharmacogenetics implementation consortium (CPIC) guidelines for codeine therapy in the context of cytochrome p450 2d6 (CYP2D6) genotype. Clin Pharmacol Ther. 2012;91(2):321\u20136. https:\/\/doi.org\/10.1038\/clpt.2011.287.","journal-title":"Clin Pharmacol Ther"},{"issue":"4","key":"1329_CR55","doi-asserted-by":"publisher","DOI":"10.1038\/s41397-025-00379-w","volume":"25","author":"S Jethwa","year":"2025","unstructured":"Jethwa S, Ball M, Langlands K. Pharmacogenomic-guided opioid therapy for pain: a systematic review and meta-analysis of randomised controlled trials. Pharmacogenomics J. 2025;25(4):20. https:\/\/doi.org\/10.1038\/s41397-025-00379-w.","journal-title":"Pharmacogenomics J"},{"issue":"10","key":"1329_CR56","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1111\/bcp.14094","volume":"86","author":"AC Drenth\u2010van Maanen","year":"2020","unstructured":"Drenth\u2010van Maanen AC, Wilting I, Jansen PAF. Prescribing medicines to older people\u2014how to consider the impact of ageing on human organ and body functions. Br J Clin Pharmacol. 2020;86(10):1921\u201330. https:\/\/doi.org\/10.1111\/bcp.14094.","journal-title":"Br J Clin Pharmacol"},{"key":"1329_CR57","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-024-01466-0","author":"NN Ngcobo","year":"2025","unstructured":"Ngcobo NN. Influence of ageing on the pharmacodynamics and pharmacokinetics of chronically administered medicines in geriatric patients: a review. Clin Pharmacokinet. 2025. https:\/\/doi.org\/10.1007\/s40262-024-01466-0.","journal-title":"Clin Pharmacokinet"},{"issue":"8","key":"1329_CR58","doi-asserted-by":"publisher","first-page":"3197","DOI":"10.1111\/bcp.14735","volume":"87","author":"CD Bruno","year":"2021","unstructured":"Bruno CD, Harmatz JS, Duan SX, Zhang Q, Chow CR, Greenblatt DJ. Effect of lipophilicity on drug distribution and elimination: influence of obesity. Br J Clin Pharmacol. 2021;87(8):3197\u2013205. https:\/\/doi.org\/10.1111\/bcp.14735.","journal-title":"Br J Clin Pharmacol"},{"issue":"6","key":"1329_CR59","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1007\/s40266-024-01117-w","volume":"41","author":"N Gronich","year":"2024","unstructured":"Gronich N. Central nervous system medications: pharmacokinetic and pharmacodynamic considerations for older adults. Drugs Aging. 2024;41(6):507\u201319. https:\/\/doi.org\/10.1007\/s40266-024-01117-w.","journal-title":"Drugs Aging"},{"issue":"7","key":"1329_CR60","doi-asserted-by":"publisher","first-page":"601","DOI":"10.2174\/138920011796504527","volume":"12","author":"S Shi","year":"2011","unstructured":"Shi S, Klotz U. Age-related changes in pharmacokinetics. Curr Drug Metab. 2011;12(7):601\u201310. https:\/\/doi.org\/10.2174\/138920011796504527.","journal-title":"Curr Drug Metab"},{"issue":"2","key":"1329_CR61","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1093\/gerona\/glr118","volume":"67A","author":"AJ McLachlan","year":"2012","unstructured":"McLachlan AJ, Pont LG. Drug metabolism in older people\u2014a key consideration in achieving optimal outcomes with medicines. J Gerontol A Biol Sci Med Sci. 2012;67A(2):175\u201380. https:\/\/doi.org\/10.1093\/gerona\/glr118.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"6","key":"1329_CR62","doi-asserted-by":"publisher","first-page":"752","DOI":"10.2174\/138945010791170879","volume":"11","author":"P Niscola","year":"2010","unstructured":"Niscola P, Scaramucci L, Vischini G, Giovannini M, Ferrannini M, Massa P, et al. The use of major analgesics in patients with renal dysfunction. Curr Drug Targets. 2010;11(6):752\u20138. https:\/\/doi.org\/10.2174\/138945010791170879.","journal-title":"Curr Drug Targets"},{"issue":"5","key":"1329_CR63","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1177\/0269216310383739","volume":"25","author":"L Radbruch","year":"2011","unstructured":"Radbruch L, Trottenberg P, Elsner F, Kaasa S, Caraceni A. Systematic review of the role of alternative application routes for opioid treatment for moderate to severe cancer pain: an EPCRC opioid guidelines project. Palliat Med. 2011;25(5):578\u201396. https:\/\/doi.org\/10.1177\/0269216310383739.","journal-title":"Palliat Med"},{"issue":"3","key":"1329_CR64","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1177\/030089169808400302","volume":"84","author":"C Ripamonti","year":"1998","unstructured":"Ripamonti C, Zecca E, De Conno F. Pharmacological treatment of cancer pain: alternative routes of opioid administration. Tumori. 1998;84(3):289\u2013300. https:\/\/doi.org\/10.1177\/030089169808400302.","journal-title":"Tumori"},{"issue":"3","key":"1329_CR65","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1097\/JCP.0b013e3182189892","volume":"31","author":"A Liukas","year":"2011","unstructured":"Liukas A, Hagelberg NM, Kuusniemi K, Neuvonen PJ, Olkkola KT. Inhibition of cytochrome p450 3a by clarithromycin uniformly affects the pharmacokinetics and pharmacodynamics of oxycodone in young and elderly volunteers. J Clin Psychopharmacol. 2011;31(3):302\u20138. https:\/\/doi.org\/10.1097\/JCP.0b013e3182189892.","journal-title":"J Clin Psychopharmacol"},{"issue":"12","key":"1329_CR66","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1007\/s40266-015-0315-4","volume":"32","author":"S Skinner-Robertson","year":"2015","unstructured":"Skinner-Robertson S, Fradette C, Bouchard S, Mouksassi MS, Varin F. Pharmacokinetics of tramadol and o-desmethyltramadol enantiomers following administration of extended-release tablets to elderly and young subjects. Drugs Aging. 2015;32(12):1029\u201343. https:\/\/doi.org\/10.1007\/s40266-015-0315-4.","journal-title":"Drugs Aging"},{"issue":"2","key":"1329_CR67","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s00228-012-1320-8","volume":"69","author":"N Al-Tawil","year":"2013","unstructured":"Al-Tawil N, Odar-Cederl\u00f6f I, Berggren AC, Johnson HE, Persson J. Pharmacokinetics of transdermal buprenorphine patch in the elderly. Eur J Clin Pharmacol. 2013;69(2):143\u20139. https:\/\/doi.org\/10.1007\/s00228-012-1320-8.","journal-title":"Eur J Clin Pharmacol"},{"issue":"8","key":"1329_CR68","doi-asserted-by":"publisher","first-page":"615","DOI":"10.2165\/11632620-000000000-00000","volume":"29","author":"AL van Ojik","year":"2012","unstructured":"van Ojik AL, Jansen PAF, Brouwers JRBJ, van Roon EN. Treatment of chronic pain in older people. Drugs Aging. 2012;29(8):615\u201325. https:\/\/doi.org\/10.2165\/11632620-000000000-00000.","journal-title":"Drugs Aging"},{"issue":"12","key":"1329_CR69","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1007\/s40266-024-01151-8","volume":"41","author":"G Pickering","year":"2024","unstructured":"Pickering G, Kotli\u0144ska-Lemieszek A, Krcevski Skvarc N, O\u2019Mahony D, Monacelli F, Knaggs R, et al. Pharmacological pain treatment in older persons. Drugs Aging. 2024;41(12):959\u201376. https:\/\/doi.org\/10.1007\/s40266-024-01151-8.","journal-title":"Drugs Aging"},{"issue":"2","key":"1329_CR70","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1111\/bcp.13129","volume":"83","author":"EJM Kuip","year":"2017","unstructured":"Kuip EJM, Zandvliet ML, Koolen SLW, Mathijssen RHJ, van der Rijt CCD. A review of factors explaining variability in fentanyl pharmacokinetics; focus on implications for cancer patients. Br J Clin Pharmacol. 2017;83(2):294\u2013313. https:\/\/doi.org\/10.1111\/bcp.13129.","journal-title":"Br J Clin Pharmacol"},{"issue":"4","key":"1329_CR71","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1056\/NEJMra1800222","volume":"380","author":"JAJ Martyn","year":"2019","unstructured":"Martyn JAJ, Mao J, Bittner EA. Opioid tolerance in critical illness. N Engl J Med. 2019;380(4):365\u201378. https:\/\/doi.org\/10.1056\/NEJMra1800222.","journal-title":"N Engl J Med"},{"issue":"1","key":"1329_CR72","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1046\/j.1365-2125.2003.02007.x","volume":"57","author":"AA Mangoni","year":"2004","unstructured":"Mangoni AA, Jackson SHD. Age\u2010related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications. Br J Clin Pharmacol. 2004;57(1):6\u201314. https:\/\/doi.org\/10.1046\/j.1365-2125.2003.02007.x.","journal-title":"Br J Clin Pharmacol"},{"issue":"9","key":"1329_CR73","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1097\/AJP.0b013e31821d8ac1","volume":"27","author":"HS Smith","year":"2011","unstructured":"Smith HS. The metabolism of opioid agents and the clinical impact of their active metabolites. Clin J Pain. 2011;27(9):824\u201338. https:\/\/doi.org\/10.1097\/AJP.0b013e31821d8ac1.","journal-title":"Clin J Pain"},{"issue":"2","key":"1329_CR74","doi-asserted-by":"publisher","first-page":"151","DOI":"10.2147\/tcrm.1.2.151.62914","volume":"1","author":"SN Hilmer","year":"2005","unstructured":"Hilmer SN, Shenfield GM, Le Couteur DG. Clinical implications of changes in hepatic drug metabolism in older people. Ther Clin Risk Manag. 2005;1(2):151\u20136. https:\/\/doi.org\/10.2147\/tcrm.1.2.151.62914.","journal-title":"Ther Clin Risk Manag"},{"issue":"2","key":"1329_CR75","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1080\/03602532.2017.1293682","volume":"49","author":"G Yang","year":"2017","unstructured":"Yang G, Ge S, Singh R, Basu S, Shatzer K, Zen M, et al. Glucuronidation: driving factors and their impact on glucuronide disposition. Drug Metab Rev. 2017;49(2):105\u201338. https:\/\/doi.org\/10.1080\/03602532.2017.1293682.","journal-title":"Drug Metab Rev"},{"issue":"12","key":"1329_CR76","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1007\/s40266-015-0318-1","volume":"32","author":"JL Tan","year":"2015","unstructured":"Tan JL, Eastment JG, Poudel A, Hubbard RE. Age-related changes in hepatic function: an update on implications for drug therapy. Drugs Aging. 2015;32(12):999\u20131008. https:\/\/doi.org\/10.1007\/s40266-015-0318-1.","journal-title":"Drugs Aging"},{"issue":"3","key":"1329_CR77","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1159\/000052829","volume":"48","author":"J Zeeh","year":"2002","unstructured":"Zeeh J, Platt D. The aging liver. Gerontology. 2002;48(3):121\u20137. https:\/\/doi.org\/10.1159\/000052829.","journal-title":"Gerontology"},{"key":"1329_CR78","doi-asserted-by":"publisher","first-page":"821","DOI":"10.2147\/TCRM.S262843","volume":"16","author":"F Coluzzi","year":"2020","unstructured":"Coluzzi F, Caputi FF, Billeci D, Pastore AL, Candeletti S, Rocco M, et al. Safe Use of opioids in chronic kidney disease and hemodialysis patients: tips and tricks for non-pain specialists. Ther Clin Risk Manag. 2020;16:821\u201337. https:\/\/doi.org\/10.2147\/TCRM.S262843.","journal-title":"Ther Clin Risk Manag"},{"issue":"2","key":"1329_CR79","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s00228-008-0570-y","volume":"65","author":"JK Coller","year":"2009","unstructured":"Coller JK, Christrup LL, Somogyi AA. Role of active metabolites in the use of opioids. Eur J Clin Pharmacol. 2009;65(2):121\u201339. https:\/\/doi.org\/10.1007\/s00228-008-0570-y.","journal-title":"Eur J Clin Pharmacol"},{"key":"1329_CR80","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3389\/fnagi.2016.00144","volume":"16","author":"M Prostran","year":"2016","unstructured":"Prostran M, Vujovi\u0107 KS, Vu\u010dkovi\u0107 S, Medi\u0107 B, Srebro D, Divac N, et al. Pharmacotherapy of pain in the older population: the place of opioids. Front Aging Neurosci. 2016;16:8. https:\/\/doi.org\/10.3389\/fnagi.2016.00144.","journal-title":"Front Aging Neurosci."},{"issue":"4","key":"1329_CR81","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1200\/JCO.22.02198","volume":"41","author":"JA Paice","year":"2023","unstructured":"Paice JA, Bohlke K, Barton D, Craig DS, El-Jawahri A, Hershman DL, et al. Use of opioids for adults with pain from cancer or cancer treatment: ASCO guideline. J Clin Oncol. 2023;41(4):914\u201330. https:\/\/doi.org\/10.1200\/JCO.22.02198.","journal-title":"J Clin Oncol"},{"issue":"12","key":"1329_CR82","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1016\/j.amjmed.2019.06.014","volume":"132","author":"MT Owsiany","year":"2019","unstructured":"Owsiany MT, Hawley CE, Triantafylidis LK, Paik JM. Opioid management in older adults with chronic kidney disease: a review. Am J Med. 2019;132(12):1386\u201393. https:\/\/doi.org\/10.1016\/j.amjmed.2019.06.014.","journal-title":"Am J Med"},{"issue":"10","key":"1329_CR83","doi-asserted-by":"publisher","first-page":"671","DOI":"10.2165\/11535390-000000000-00000","volume":"49","author":"XS Xu","year":"2010","unstructured":"Xu XS, Smit JW, Lin R, Stuyckens K, Terlinden R, Nandy P. Population pharmacokinetics of tapentadol immediate release (IR) in healthy subjects and patients with moderate or severe pain. Clin Pharmacokinet. 2010;49(10):671\u201382. https:\/\/doi.org\/10.2165\/11535390-000000000-00000.","journal-title":"Clin Pharmacokinet"},{"issue":"4","key":"1329_CR84","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/j.cger.2016.06.006","volume":"32","author":"JG Naples","year":"2016","unstructured":"Naples JG, Gellad WF, Hanlon JT. The role of opioid analgesics in geriatric pain management. Clin Geriatr Med. 2016;32(4):725\u201335. https:\/\/doi.org\/10.1016\/j.cger.2016.06.006.","journal-title":"Clin Geriatr Med"},{"issue":"1","key":"1329_CR85","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s44158-024-00182-2","volume":"4","author":"S Mercadante","year":"2024","unstructured":"Mercadante S. Influence of aging on opioid dosing for perioperative pain management: a focus on pharmacokinetics. J Anesth Analg Criti Care. 2024;4(1):51. https:\/\/doi.org\/10.1186\/s44158-024-00182-2.","journal-title":"J Anesth Analg Criti Care."},{"key":"1329_CR86","doi-asserted-by":"publisher","DOI":"10.12788\/fp.0110","author":"N Azubike","year":"2021","unstructured":"Azubike N. Opioid management in older adults: lessons learned from a geriatric patient-centered medical home. Federal Pract. 2021. https:\/\/doi.org\/10.12788\/fp.0110.","journal-title":"Federal Pract"},{"issue":"suppl 1","key":"1329_CR87","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1111\/j.1526-4637.2010.00992.x","volume":"12","author":"KL Kirsh","year":"2011","unstructured":"Kirsh KL, Fishman SM. Multimodal approaches to optimize outcomes of chronic opioid therapy in the management of chronic pain. Pain Med. 2011;12(suppl 1):S1-11. https:\/\/doi.org\/10.1111\/j.1526-4637.2010.00992.x.","journal-title":"Pain Med"},{"key":"1329_CR88","unstructured":"Anekar A, Hendrix J, Cascella M. WHO analgesic ladder. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK554435\/. Accessed 23 Apr 2023."},{"key":"1329_CR89","unstructured":"Rogers E, Mehta S, Shengelia R, Reid M. Four strategies for managing opioid-induced side effects in older adults. Clin Geriatr. 2013;21(4). http:\/\/www.consultant360.com\/articles\/four-strategies-managing-opioid-induced-side-effects-older-adults."},{"key":"1329_CR90","doi-asserted-by":"publisher","DOI":"10.1111\/nmo.13601","author":"A Babaei","year":"2019","unstructured":"Babaei A, Szabo A, Shad S, Massey BT. Chronic daily opioid exposure is associated with dysphagia, esophageal outflow obstruction, and disordered peristalsis. Neurogastroenterol Motil. 2019. https:\/\/doi.org\/10.1111\/nmo.13601.","journal-title":"Neurogastroenterol Motil."},{"issue":"1","key":"1329_CR91","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-99858-w","volume":"11","author":"U Wolf","year":"2021","unstructured":"Wolf U, Eckert S, Walter G, Wienke A, Bartel S, Plontke SK, et al. Prevalence of oropharyngeal dysphagia in geriatric patients and real-life associations with diseases and drugs. Sci Rep. 2021;11(1):21955. https:\/\/doi.org\/10.1038\/s41598-021-99858-w.","journal-title":"Sci Rep"},{"key":"1329_CR92","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2018\/8610538","volume":"2018","author":"M Gol\u010di\u0107","year":"2018","unstructured":"Gol\u010di\u0107 M, Dobrila-Dintinjana R, Gol\u010di\u0107 G, Govi\u0107-Gol\u010di\u0107 L. Differences between transdermal fentanyl and buprenorphine in the elderly hospice patients. Pain Res Treat. 2018;2018:1\u20135. https:\/\/doi.org\/10.1155\/2018\/8610538.","journal-title":"Pain Res Treat"},{"key":"1329_CR93","doi-asserted-by":"publisher","first-page":"233","DOI":"10.2147\/DDDT.S414318","volume":"18","author":"Q Fu","year":"2024","unstructured":"Fu Q, Han N, Li N, Gui L, Shi C, Rong P, et al. Guidelines for rational clinical use of fentanyl transdermal patch. Drug Des Dev Ther. 2024;18:233\u201355. https:\/\/doi.org\/10.2147\/DDDT.S414318.","journal-title":"Drug Des Dev Ther"},{"key":"1329_CR94","doi-asserted-by":"publisher","first-page":"421","DOI":"10.2147\/CIA.S1880","volume":"3","author":"N Vadivelu","year":"2008","unstructured":"Vadivelu N, Hines R. Management of chronic pain in the elderly: focus on transdermal buprenorphine. Clin Interv Aging. 2008;3:421\u201330. https:\/\/doi.org\/10.2147\/CIA.S1880.","journal-title":"Clin Interv Aging"},{"issue":"2","key":"1329_CR95","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1089\/jpm.2006.0150","volume":"10","author":"GM Reisfield","year":"2007","unstructured":"Reisfield GM, Wilson GR. Rational use of sublingual opioids in palliative medicine. J Palliat Med. 2007;10(2):465\u201375. https:\/\/doi.org\/10.1089\/jpm.2006.0150.","journal-title":"J Palliat Med"},{"issue":"11","key":"1329_CR96","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1185\/03007995.2012.735227","volume":"28","author":"N Moore","year":"2012","unstructured":"Moore N, Darwish M, Amores X, Schneid H. A review of the pharmacokinetic profile of transmucosal fentanyl formulations. Curr Med Res Opin. 2012;28(11):1781\u201390. https:\/\/doi.org\/10.1185\/03007995.2012.735227.","journal-title":"Curr Med Res Opin"},{"issue":"8","key":"1329_CR97","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics17081073","volume":"17","author":"S Bahraminejad","year":"2025","unstructured":"Bahraminejad S, Almoazen H. Sublingual and buccal delivery: a historical and scientific prescriptive. Pharmaceutics. 2025;17(8):1073. https:\/\/doi.org\/10.3390\/pharmaceutics17081073.","journal-title":"Pharmaceutics"},{"issue":"4","key":"1329_CR98","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.jpainsymman.2013.10.018","volume":"48","author":"L Bartz","year":"2014","unstructured":"Bartz L, Klein C, Seifert A, Herget I, Ostgathe C, Stiel S. Subcutaneous administration of drugs in palliative care: results of a systematic observational study. J Pain Symptom Manag. 2014;48(4):540\u20137. https:\/\/doi.org\/10.1016\/j.jpainsymman.2013.10.018.","journal-title":"J Pain Symptom Manag"},{"issue":"2","key":"1329_CR99","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1177\/20494637221135835","volume":"17","author":"L Fairbairn","year":"2023","unstructured":"Fairbairn L, Schuberth A, Deacon L, Gilkes H, Montgomery V, Bennett MI, et al. A systematic review of subcutaneous versus intramuscular or intravenous routes of opioid administration on pain outcomes in cancer and post-surgical clinical populations\u2014challenging current assumptions in palliative care practice. Br J Pain. 2023;17(2):152\u201365. https:\/\/doi.org\/10.1177\/20494637221135835.","journal-title":"Br J Pain"},{"key":"1329_CR100","doi-asserted-by":"publisher","DOI":"10.1111\/opn.12655","author":"N Yalcin Atar","year":"2024","unstructured":"Yalcin Atar N, Altan MD, Kaymaz E. Examining the safety of dorsogluteal and ventrogluteal sites for intramuscular injection in older adults. Int J Older People Nurs. 2024. https:\/\/doi.org\/10.1111\/opn.12655.","journal-title":"Int J Older People Nurs"},{"issue":"1","key":"1329_CR101","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1177\/2049463712439256","volume":"6","author":"P Farquhar-Smith","year":"2012","unstructured":"Farquhar-Smith P, Chapman S. Neuraxial (epidural and intrathecal) opioids for intractable pain. Br J Pain. 2012;6(1):25\u201335. https:\/\/doi.org\/10.1177\/2049463712439256.","journal-title":"Br J Pain"},{"issue":"5","key":"1329_CR102","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1016\/j.jpainsymman.2009.09.015","volume":"39","author":"S Yennurajalingam","year":"2010","unstructured":"Yennurajalingam S, Dev R, Walker PW, Reddy SK, Bruera E. Challenges associated with spinal opioid therapy for pain in patients with advanced cancer: a report of three cases. J Pain Symptom Manag. 2010;39(5):930\u20135. https:\/\/doi.org\/10.1016\/j.jpainsymman.2009.09.015.","journal-title":"J Pain Symptom Manag"},{"issue":"9","key":"1329_CR103","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1007\/s40266-019-00692-7","volume":"36","author":"B Kleinmann","year":"2019","unstructured":"Kleinmann B, Wolter T. Managing chronic non-malignant pain in the elderly: intrathecal therapy. Drugs Aging. 2019;36(9):789\u201397. https:\/\/doi.org\/10.1007\/s40266-019-00692-7.","journal-title":"Drugs Aging"},{"issue":"1","key":"1329_CR104","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0304-3959(98)00118-3","volume":"79","author":"S Mercadante","year":"1999","unstructured":"Mercadante S. Problems of long-term spinal opioid treatment in advanced cancer patients. Pain. 1999;79(1):1\u201313. https:\/\/doi.org\/10.1016\/S0304-3959(98)00118-3.","journal-title":"Pain"},{"issue":"7","key":"1329_CR105","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1111\/pme.12464","volume":"15","author":"MG Kestenbaum","year":"2014","unstructured":"Kestenbaum MG, Vilches AO, Messersmith S, Connor SR, Fine PG, Murphy B, et al. Alternative routes to oral opioid administration in palliative care: a review and clinical summary. Pain Med. 2014;15(7):1129\u201353. https:\/\/doi.org\/10.1111\/pme.12464.","journal-title":"Pain Med"},{"issue":"2","key":"1329_CR106","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s00520-001-0311-6","volume":"10","author":"MP Davis","year":"2002","unstructured":"Davis MP, Walsh D, LeGrand SB, Naughton M. Symptom control in cancer patients: the clinical pharmacology and therapeutic role of suppositories and rectal suspensions. Support Care Cancer. 2002;10(2):117\u201338. https:\/\/doi.org\/10.1007\/s00520-001-0311-6.","journal-title":"Support Care Cancer"},{"issue":"2","key":"1329_CR107","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.anclin.2026.02.014","volume":"44","author":"B Beck","year":"2026","unstructured":"Beck B, Lebak K, Lane O. Perioperative management of patients on medication for opioid use disorder undergoing ambulatory surgery. Anesthesiol Clin. 2026;44(2):383\u201394. https:\/\/doi.org\/10.1016\/j.anclin.2026.02.014.","journal-title":"Anesthesiol Clin"},{"issue":"10","key":"1329_CR108","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1093\/pm\/pnab110","volume":"22","author":"SM Nugent","year":"2021","unstructured":"Nugent SM, Lovejoy TI, Shull S, Dobscha SK, Morasco BJ. Associations of pain numeric rating scale scores collected during usual care with research administered patient reported pain outcomes. Pain Med. 2021;22(10):2235\u201341. https:\/\/doi.org\/10.1093\/pm\/pnab110.","journal-title":"Pain Med"},{"issue":"1","key":"1329_CR109","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1097\/01.JAM.0000043422.31640.F7","volume":"4","author":"V Warden","year":"2003","unstructured":"Warden V, Hurley AC, Volicer L. Development and psychometric evaluation of the pain assessment in advanced dementia (PAINAD) scale. J Am Med Dir Assoc. 2003;4(1):9\u201315. https:\/\/doi.org\/10.1097\/01.JAM.0000043422.31640.F7.","journal-title":"J Am Med Dir Assoc"},{"issue":"1","key":"1329_CR110","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.cger.2024.03.011","volume":"41","author":"K Rajput","year":"2025","unstructured":"Rajput K, Ng J, Zwolinski N, Chow RM. Pain management in the older adults. Clin Geriatr Med. 2025;41(1):131\u201351. https:\/\/doi.org\/10.1016\/j.cger.2024.03.011.","journal-title":"Clin Geriatr Med"},{"key":"1329_CR111","doi-asserted-by":"publisher","first-page":"vi69","DOI":"10.1093\/annonc\/mdr390","volume":"22","author":"CI Ripamonti","year":"2011","unstructured":"Ripamonti CI, Bandieri E, Roila F. Management of cancer pain: ESMO clinical practice guidelines. Ann Oncol. 2011;22:vi69\u201377. https:\/\/doi.org\/10.1093\/annonc\/mdr390.","journal-title":"Ann Oncol."},{"issue":"2","key":"1329_CR112","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1136\/annrheumdis-2016-209724","volume":"76","author":"GJ Macfarlane","year":"2017","unstructured":"Macfarlane GJ, Kronisch C, Dean LE, Atzeni F, H\u00e4user W, Flu\u00df E, et al. EULAR revised recommendations for the management of fibromyalgia. Ann Rheum Dis. 2017;76(2):318\u201328. https:\/\/doi.org\/10.1136\/annrheumdis-2016-209724.","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"1329_CR113","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.reumae.2021.02.002","volume":"18","author":"J Rivera Redondo","year":"2022","unstructured":"Rivera Redondo J, D\u00edaz del Campo Fontecha P, Alegre de Miquel C, AlmirallBernab\u00e9 M, CasanuevaFern\u00e1ndez B, Castillo Ojeda C, et al. Recommendations by the Spanish society of rheumatology on fibromyalgia. Part 1: diagnosis and treatment. Reumatol Cl\u00edn (English Edition). 2022;18(3):131\u201340. https:\/\/doi.org\/10.1016\/j.reumae.2021.02.002.","journal-title":"Reumatol Cl\u00edn (English Edition)"},{"issue":"1","key":"1329_CR114","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1136\/annrheumdis-2018-213826","volume":"78","author":"M Kloppenburg","year":"2018","unstructured":"Kloppenburg M, Kroon FP, Blanco FJ, Doherty M, Dziedzic KS, Greibrokk E, et al. 2018 update of the EULAR recommendations for the management of hand osteoarthritis. Ann Rheum Dis. 2018;78(1):16\u201324. https:\/\/doi.org\/10.1136\/annrheumdis-2018-213826.","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"1329_CR115","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1002\/art.41142","volume":"72","author":"SL Kolasinski","year":"2019","unstructured":"Kolasinski SL, Neogi T, Hochberg MC, Oatis C, Guyatt G, Block J, et al. 2019 American College of Rheumatology\/Arthritis Foundation guideline for the management of osteoarthritis of the hand, hip, and knee. Arthritis Rheumatol. 2019;72(2):220\u201333. https:\/\/doi.org\/10.1002\/art.41142.","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"1329_CR116","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1136\/ard-2022-223296","volume":"82","author":"S Ramiro","year":"2022","unstructured":"Ramiro S, Nikiphorou E, Sepriano A, Ortolan A, Webers C, Baraliakos X, et al. ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update. Ann Rheum Dis. 2022;82(1):19\u201334. https:\/\/doi.org\/10.1136\/ard-2022-223296.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"1329_CR117","first-page":"7","volume":"45","author":"S Azevedo","year":"2020","unstructured":"Azevedo S, Guimar\u00e3es F, Leite Silva J, Barros R, Capela S, Abreu P, et al. The role of opioid analgesics in rheumatic disorders: a position paper from the Portuguese Rheumatology Society. Acta Reumatol Port. 2020;45(1):7\u201319.","journal-title":"Acta Reumatol Port"},{"issue":"9","key":"1329_CR118","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1001\/jama.2018.0899","volume":"319","author":"EE Krebs","year":"2018","unstructured":"Krebs EE, Gravely A, Nugent S, Jensen AC, DeRonne B, Goldsmith ES, et al. Effect of opioid vs nonopioid medications on pain-related function in patients with chronic back pain or hip or knee osteoarthritis pain. JAMA. 2018;319(9):872. https:\/\/doi.org\/10.1001\/jama.2018.0899.","journal-title":"JAMA"},{"issue":"4","key":"1329_CR119","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11040510","volume":"11","author":"A Caraceni","year":"2019","unstructured":"Caraceni A, Shkodra M. Cancer pain assessment and classification. Cancers (Basel). 2019;11(4):510. https:\/\/doi.org\/10.3390\/cancers11040510.","journal-title":"Cancers (Basel)"},{"issue":"3","key":"1329_CR120","doi-asserted-by":"publisher","first-page":"248","DOI":"10.4103\/apjon.apjon_11_18","volume":"5","author":"JM Brant","year":"2018","unstructured":"Brant JM. Assessment and management of cancer pain in older adults: strategies for success. Asia Pac J Oncol Nurs. 2018;5(3):248\u201353. https:\/\/doi.org\/10.4103\/apjon.apjon_11_18.","journal-title":"Asia Pac J Oncol Nurs"},{"key":"1329_CR121","volume-title":"WHO guidelines for the pharmacological and radiotherapeutic management of cancer pain in adults and adolescents","author":"World Health Organization","year":"2018","unstructured":"World Health Organization. WHO guidelines for the pharmacological and radiotherapeutic management of cancer pain in adults and adolescents. Geneva: World Health Organization; 2018."},{"issue":"27","key":"1329_CR122","doi-asserted-by":"publisher","first-page":"3325","DOI":"10.1200\/JCO.2016.68.5206","volume":"34","author":"JA Paice","year":"2016","unstructured":"Paice JA, Portenoy R, Lacchetti C, Campbell T, Cheville A, Citron M, et al. Management of chronic pain in survivors of adult cancers: American Society of Clinical Oncology Clinical Practice Guideline. J Clin Oncol. 2016;34(27):3325\u201345. https:\/\/doi.org\/10.1200\/JCO.2016.68.5206.","journal-title":"J Clin Oncol"},{"issue":"12","key":"1329_CR123","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1038\/nrclinonc.2010.170","volume":"7","author":"C Oakman","year":"2010","unstructured":"Oakman C, Santarpia L, Di Leo A. Breast cancer assessment tools and optimizing adjuvant therapy. Nat Rev Clin Oncol. 2010;7(12):725\u201332. https:\/\/doi.org\/10.1038\/nrclinonc.2010.170.","journal-title":"Nat Rev Clin Oncol"},{"key":"1329_CR124","unstructured":"NICE guidelines. Opioids in palliative care: safe and effective prescribing of strong opioids for pain in palliative care of adults. Opioids in palliative care: evidence update May 2014: a summary of selected new evidence relevant to NICE clinical guideline London: National Institute for Health and Care Excellence (NICE); 2014 (Evidence Update, No 58)."},{"key":"1329_CR125","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.2147\/JPR.S140320","volume":"10","author":"JS Ahn","year":"2017","unstructured":"Ahn JS, Lin J, Ogawa S, Chen Y, O\u2019Brien T, Le B, et al. Transdermal buprenorphine and fentanyl patches in cancer pain: a network systematic review. J Pain Res. 2017;10:1963\u201372. https:\/\/doi.org\/10.2147\/JPR.S140320.","journal-title":"J Pain Res"},{"key":"1329_CR126","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010270.pub2","author":"G Hadley","year":"2013","unstructured":"Hadley G, Derry S, Moore RA, Wiffen PJ. Transdermal fentanyl for cancer pain. Cochrane Database Syst Rev. 2013. https:\/\/doi.org\/10.1002\/14651858.CD010270.pub2.","journal-title":"Cochrane Database Syst Rev."},{"key":"1329_CR127","doi-asserted-by":"publisher","DOI":"10.2147\/CMR.S7926","author":"W Leppert","year":"2010","unstructured":"Leppert W. Role of intranasal fentanyl in breakthrough pain management in cancer patients. Cancer Manag Res. 2010. https:\/\/doi.org\/10.2147\/CMR.S7926.","journal-title":"Cancer Manag Res."},{"issue":"1","key":"1329_CR128","doi-asserted-by":"publisher","first-page":"22","DOI":"10.12701\/jyms.2023.00367","volume":"41","author":"J Yeo","year":"2024","unstructured":"Yeo J. Breakthrough pain and rapid-onset opioids in patients with cancer pain: a narrative review. J Yeungnam Med Sci. 2024;41(1):22\u20139. https:\/\/doi.org\/10.12701\/jyms.2023.00367.","journal-title":"J Yeungnam Med Sci"},{"issue":"2","key":"1329_CR129","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2025.58299","volume":"9","author":"LH Cavallari","year":"2026","unstructured":"Cavallari LH, Myers RA, Chakraborty H, Skaar TC, Gray CF, Baye JF, et al. CYP2D6-guided opioid management and postoperative pain control. JAMA Netw Open. 2026;9(2):e2558299. https:\/\/doi.org\/10.1001\/jamanetworkopen.2025.58299.","journal-title":"JAMA Netw Open"},{"issue":"10","key":"1329_CR130","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1007\/s11864-022-01010-x","volume":"23","author":"AK Wong","year":"2022","unstructured":"Wong AK, Somogyi AA, Rubio J, Philip J. The role of pharmacogenomics in opioid prescribing. Curr Treat Opt Oncol. 2022;23(10):1353\u201369. https:\/\/doi.org\/10.1007\/s11864-022-01010-x.","journal-title":"Curr Treat Opt Oncol"},{"issue":"7","key":"1329_CR131","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1007\/s11864-023-01091-2","volume":"24","author":"A Bradley","year":"2023","unstructured":"Bradley A, Boland JW. Effects of opioids on immune and endocrine function in patients with cancer pain. Curr Treat Opt Oncol. 2023;24(7):867\u201379. https:\/\/doi.org\/10.1007\/s11864-023-01091-2.","journal-title":"Curr Treat Opt Oncol"},{"key":"1329_CR132","doi-asserted-by":"publisher","DOI":"10.37349\/ei.2026.1003251","author":"LD Voiculescu","year":"2026","unstructured":"Voiculescu LD, Li T, Liongson FA, Menghani S. Balancing analgesia and immunity: revisiting the immune consequences of opioid therapy. Explor Immunol. 2026. https:\/\/doi.org\/10.37349\/ei.2026.1003251.","journal-title":"Explor Immunol"},{"issue":"14","key":"1329_CR133","doi-asserted-by":"publisher","first-page":"2726","DOI":"10.1111\/bph.13903","volume":"175","author":"JW Boland","year":"2018","unstructured":"Boland JW, Pockley AG. Influence of opioids on immune function in patients with cancer pain: from bench to bedside. Br J Pharmacol. 2018;175(14):2726\u201336. https:\/\/doi.org\/10.1111\/bph.13903.","journal-title":"Br J Pharmacol"},{"key":"1329_CR134","doi-asserted-by":"publisher","first-page":"145","DOI":"10.36076\/ppj.2011\/14\/145","volume":"14","author":"M Lee","year":"2011","unstructured":"Lee M, Silverman S, Hansen H, Patel V, Manchikanti L. A comprehensive review of opioid-induced hyperalgesia. Pain Physician. 2011;14:145\u201361.","journal-title":"Pain Physician"},{"issue":"4","key":"1329_CR135","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1007\/s13181-012-0260-0","volume":"8","author":"DE Brush","year":"2012","unstructured":"Brush DE. Complications of long-term opioid therapy for management of chronic pain: the paradox of opioid-induced hyperalgesia. J Med Toxicol. 2012;8(4):387\u201392. https:\/\/doi.org\/10.1007\/s13181-012-0260-0.","journal-title":"J Med Toxicol"},{"issue":"23","key":"1329_CR136","doi-asserted-by":"publisher","first-page":"2246","DOI":"10.1056\/NEJMra1807054","volume":"380","author":"KM Babu","year":"2019","unstructured":"Babu KM, Brent J, Juurlink DN. Prevention of opioid overdose. N Engl J Med. 2019;380(23):2246\u201355. https:\/\/doi.org\/10.1056\/NEJMra1807054.","journal-title":"N Engl J Med"},{"issue":"17","key":"1329_CR137","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1001\/jama.2026.3241","volume":"335","author":"TD Nguyen","year":"2026","unstructured":"Nguyen TD, Chua KP, Jiao A, Bicket MC, Bohnert A, Lagisetty P. US trends in long-term opioid therapy. JAMA. 2026;335(17):1529. https:\/\/doi.org\/10.1001\/jama.2026.3241.","journal-title":"JAMA"},{"issue":"7","key":"1329_CR138","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1007\/s40266-025-01216-2","volume":"42","author":"J Westra","year":"2025","unstructured":"Westra J, Raji M, Baillargeon J, Aparasu RR, Kuo YF. Association between gabapentinoid use and changes in claims-based frailty among long-term opioid users. Drugs Aging. 2025;42(7):633\u201342. https:\/\/doi.org\/10.1007\/s40266-025-01216-2.","journal-title":"Drugs Aging"}],"container-title":["Drugs & Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-026-01329-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40266-026-01329-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-026-01329-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T13:11:29Z","timestamp":1789564289000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40266-026-01329-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,21]]},"references-count":138,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["1329"],"URL":"https:\/\/doi.org\/10.1007\/s40266-026-01329-2","relation":{},"ISSN":["1170-229X","1179-1969"],"issn-type":[{"value":"1170-229X","type":"print"},{"value":"1179-1969","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,21]]},"assertion":[{"value":"4 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"H.R., J.R.N., P.R., C. C.S., D.B., J.B.S., A.F., E.D., A.P., J.P.C., I.R., L.N., M.F.M., M.D., and J.P.A. declare that they have no conflicts of interest that might be relevant to the contents of this manuscript.","order":1,"name":"Ethics","label":"Conflict of Interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Conceptualization: H.R., P.R., and J.R.N.; methodology, H.R., C.C.S., J.B.S., and A.F.; software: J.R.N. and E.D.; validation: J.R.N., D.B., A.P., and J.P.C.; formal analysis: H.R., I.R., L.N., and M.F.M.; investigation: H.R., C.C.S., J.B.S., A.F., E.D., I.R., L.N., and M.F.M.; resources: H.R.; data curation, J.R.N.; writing\u2014original draft preparation: H.R., C.C.S., J.B.S., A.F., L.N., and M.F.M.; writing\u2014review and editing: J.P.A. and M.D.; visualization: J.P.A. and M.D.; supervision: M.D. and J.P.A.; project administration: H.R.; and funding acquisition: H.R., J.P.A., and J.R.N. All authors have read and approved the final version.","order":2,"name":"Ethics","label":"Author Contributions","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Ethics Approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":4,"name":"Ethics","label":"Consent (Participation and Publication)","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Data sharing not applicable to this article as no datasets were generated or analyzed during the current study.","order":5,"name":"Ethics","label":"Data Availability Statement","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":6,"name":"Ethics","label":"Code Availability","group":{"name":"EthicsHeading","label":"Declarations"}}]}}